Michael E. O'dwyer - Publications

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

Journal: Human gene therapy

Published: August 03, 2026

SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

Journal: European journal of haematology

Published: June 30, 2026

Targeting intrinsic apoptosis rewires human NK cell persistence: NOXA as a dominant survival switch.

Journal: Molecular therapy. Oncology

Published: May 07, 2026

A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer.

Journal: Device

Published: April 06, 2026

Relapsed thrombotic thrombocytopenic purpura and daratumumab utility.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: February 21, 2026

Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity.

Journal: International immunopharmacology

Published: November 18, 2025

Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters.

Journal: Frontiers in immunology

Published: October 28, 2025

Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis.

Journal: Journal for immunotherapy of cancer

Published: September 15, 2025

Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Journal: HemaSphere

Published: September 01, 2025

Turning the tide in peritoneal metastases: Locoregional CAR-NK therapy primes systemic immunity in colorectal cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 27, 2025

The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment.

Journal: European journal of immunology

Published: April 10, 2025

Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications.

Journal: Biology methods & protocols

Published: January 17, 2025